European Medicines Agency, Amsterdam, the Netherlands
The Pharmacovigilance Risk Assessment Committee (PRAC) is the committee that is responsible for assessing all aspects of the risk management of medicines for human use.
Documents
Minutes of the PRAC meeting 29 August -1 September 2017